Label: SALINOCAINE- salicylic acid and benzocaine ointment
- NDC Code(s): 10733-415-40
- Packager: Medical Products Laboratories, Inc.
- Category: HUMAN PRESCRIPTION DRUG LABEL
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated July 26, 2023
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
DIRECTIONS
Isolate verruca with adhesive tape. Remove weight bearing pressure by using felt pad with aperture. Apply Salinocaine to verruca and dress with waterproof tape to guard against water dilution. Repeat treatment every 10 days if needed.
Each Gram Contains: 550mg of Salicylic acid and 20mg of Benzocaine. Also Contains: Petrolatum, Glycerin, Benzalkonium Chloride 0.1% added as a preservative.
Premier ® Medical Products 1710 Romano Drive Plymouth Meeting, PA 19462 USA (610) 239-6053 www.premusa.com
Technology by Medical Products Laboratories, Inc. Philadelphia, PA 19115-1083, U.S.A.
For external use only.
Caution: Federal (U.S.A.) law prohibits dispensing without prescription.
Made in U.S.A.To obtain a MSDS Sheet, visit www.premusa.com or call Premier Customer Service at (610) 239-6053.
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
SALINOCAINE
salicylic acid and benzocaine ointmentProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:10733-415 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID 550 mg in 1 g BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE 20 mg in 1 g Inactive Ingredients Ingredient Name Strength PETROLATUM (UNII: 4T6H12BN9U) GLYCERIN (UNII: PDC6A3C0OX) BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:10733-415-40 40 g in 1 JAR; Type 0: Not a Combination Product 06/01/2038 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 06/01/1938 Labeler - Medical Products Laboratories, Inc. (002290302)
